New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 25, 2014
09:28 EDTCAH, ABCCardinal Health has good read through from AmerisourceBergen, says Sterne Agee
Sterne Agee believes that AmericansourceBergen's (ABC) beat and raise results bode well for Cardinal Health (CAH). The firm keeps a Buy rating on Cardinal.
News For CAH;ABC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
07:56 EDTCAHCardinal Health price target raised to $105 from $90 at Argus
Argus increased its price target on Cardinal based on what the firm sees as the company's solid Q2 results and its beneficial acquisition of Johnson & Johnsonís (JNJ) Cordis business. Argus expects Cordis to provide Cardinal with a new growth driver with higher margins. Argus keeps a Buy rating on Cardinal.
07:24 EDTCAH, ABCAmerisourceBergen can mitigate loss of PharMerica deal, says RBC Capital
Subscribe for More Information
March 2, 2015
16:26 EDTCAHOn The Fly: Closing Wrap
Subscribe for More Information
12:13 EDTCAHOn The Fly: Midday Wrap
Subscribe for More Information
11:52 EDTCAHJohnson & Johnson EPS dilution from Cordis deal seems modest, says Wells Fargo
Wells Fargo estimates that Johnson & Johnson's (JNJ) planned sale of Cordis to Cardinal Health (CAH) should dilute J&J yearly EPS by about 3c-4c, assuming all is else equal, and the firm expects the company to be able to absorb at least some of this dilution and possibly offset the rest via share repurchases. Wells maintains its Outperform rating on J&J shares.
08:12 EDTCAHPharMerica announces wholesale agreement with Cardinal Health
PharMerica Corporation (PMC) announced that it has entered into a new wholesale drug distribution agreement with Cardinal Health (CAH). The new agreement will take effect on April 1 and extend through June 2018. As part of the agreement, Cardinal Health will assume responsibility for the sourcing and distribution of branded and generic pharmaceuticals for PharMerica.
08:01 EDTCAHCardinal Health offers to buy Cordis from Johnson & Johnson in $1.99B deal
Subscribe for More Information
07:53 EDTCAHCardinal Health to host conference call
Subscribe for More Information
07:35 EDTCAHCardinal Health to buy Cordis from Johnson & Johnson in $1.99B deal
Subscribe for More Information
07:35 EDTCAHCardinal Health to acquire Cordis for $1.94B in cash
Cardinal Health (CAH) announced plans to acquire Johnson & Johnson's (JNJ) Cordis business, a global manufacturer of cardiology and endovascular devices, for $1.94B in cash, or approximately $1.59B, net of the present value of tax benefits. The acquisition is expected to be financed with a combination of $1B in new senior unsecured notes and the remainder with existing cash. The transaction is expected to close in the United States and key non-U.S. countries towards the end of calendar 2015. Assuming this timing, Cardinal Health expects fiscal 2017 accretion in non-GAAP diluted earnings per share from continuing operations of greater than 20c per share, which includes the cost of an incremental 7c-8c per share of interest expense associated with financing the transaction. The company expects the acquisition to be increasingly accretive thereafter and assumes that synergies will exceed $100M annually by the end of fiscal 2018. Cordis had annual sales in 2014 of approximately $780M, split almost evenly between cardiology and endovascular products. Upon completion of that process, Cardinal Health expects to enter into a definitive purchase and sale agreement in respect of the proposed acquisition. The proposed transaction will also be subject to customary closing conditions, including regulatory approvals, and is expected to close in the approximately 20 principal countries towards the end of calendar year 2015 and in the remaining countries on a rolling basis afterward.
February 26, 2015
14:03 EDTABCGabelli liquidates 7.69% stake in MWI Veterinary Supply
As a result of the completion of the acquisition of the company by the AmerisourceBergen (ABC), Gabelli no longer has beneficial ownership of any of the company's shares.
11:50 EDTCAHCardinal Health management to meet with William Blair
Subscribe for More Information
February 24, 2015
15:18 EDTABCAmerisourceBergen completes acquisition of MWI Veterinary Supply
AmerisourceBergen (ABC) announced the completion of its acquisition of MWI Veterinary Supply (MWIV). At the effective time of the merger, all remaining shares of MWI common stock not tendered into the tender offer were converted into the right to receive $190 in cash, without interest and less any applicable withholding taxes, which is the same price that was paid in the tender offer. As a result of the transaction, MWI has become a wholly owned subsidiary of AmerisourceBergen.
07:36 EDTABCAmerisourceBergen completes tender offer for MWI Veterinary Supply shares
AmerisourceBergen Corporation (ABC) has successfully completed its tender offer to purchase all outstanding shares of MWI Veterinary Supply (MWIV) common stock for $190.00 per share in cash, without interest and less any applicable withholding taxes. The tender offer expired at 11:59 p.m., New York City time, on February 23. As of the expiration of the tender offer, 10,096,484 shares had been validly tendered and not validly withdrawn, representing approximately 78.1% of MWI's outstanding shares of common stock on a fully diluted basis. All conditions to the tender offer have been satisfied, and AmerisourceBergen has accepted for payment and will promptly pay the depositary for all validly tendered shares. AmerisourceBergen expects to complete the acquisition of MWI later today through a merger without a vote or meeting of MWI's stockholders.
07:31 EDTCAHRBC Capital to hold a conference
Subscribe for More Information
February 22, 2015
21:52 EDTABCVascular Solutions to replace MWI Veterinary Supply in S&P 600 as of 2/23 close
S&P 500 constituent AmerisourceBergen (ABC) is acquiring MWI Veterinary Supply (MWIV) in a transaction expected to be completed soon.
12:51 EDTCAHJ&J considers Cordis sale with Cardinal the leading suitor, Bloomberg says
Subscribe for More Information
February 20, 2015
17:31 EDTCAHJ&J considering sale of Cordis with Cardinal the leading suitor, Bloomberg says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use